If you want to address civilization and society's issues, then you have to do it with the city," Urban Partners' co-CEO Claus ...

Novo Banco SA, a Portuguese lender that’s majority-owned by Lone Star, said its planned initial public offering could take ...

As part of the transaction TA, Biocomposites' majority shareholder since 2017, will reinvest in the Company alongside new investor Novo Holdings and Biocomposites' management. The transaction ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

COPENHAGEN, Denmark, Jan. 10, 2025 /PRNewswire/ -- Novo Holdings, a leading life science investor, today announced that it has invested in a $200M Series A launch financing for Windward Bio.

In December 2024, Novo Nordisk announced that the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings was completed.

Danish Novo Holdings has received approval from the European Union to acquire Catalent Inc., one of the world's largest pharmaceutical companies. This is reported in the press release of the European ...

The Series C – which was led by Novo Nordisk's parent company Novo Holdings – follows a $15 million second round for the South San Francisco-based company in 2017 and a $15 million Series A in ...